Home/Filings/4/0001179110-20-003205
4//SEC Filing

SMITH TODD N 4

Accession 0001179110-20-003205

CIK 0001586105other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 8:45 PM ET

Size

6.9 KB

Accession

0001179110-20-003205

Insider Transaction Report

Form 4
Period: 2020-03-04
SMITH TODD N
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2020-03-04+165,500165,500 total
  • Award

    Stock Option (right to buy)

    2020-03-04+241,500241,500 total
    Exercise: $1.50Exp: 2030-03-04Common Stock (241,500 underlying)
Footnotes (2)
  • [F1]Represents non-qualified stock option, 1/3 of which vests on the first anniversary of the grant date and 1/36 of which vests each month thereafter until the option is 100% vested.
  • [F2]Represents restricted stock units, which vest in three equal annual installments on the first three anniversaries of the date of grant.

Issuer

Zyla Life Sciences

CIK 0001586105

Entity typeother

Related Parties

1
  • filerCIK 0001523672

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:45 PM ET
Size
6.9 KB